Equibles does not estimate personal net worth.
Get an email with a short summary when Boston Scientific Corp publishes a filing, an earnings call transcript or a press release.
Get BSX alertsMike Mahoney is recorded as CEO at Boston Scientific Corp (BSX). Mike Mahoney has spoken on 5 earnings calls and 2 other investor events across 1 company, most recently for Boston Scientific Corp on September 10, 2026. Boston Scientific Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Boston Scientific Corp includes Michael Mahoney (CEO), Jonathan Monson (CFO), Joe Fitzgerald (COO) and 7 others.
“Very proud of what our team has done the past eight days to secure the IT systems globally, to secure distribution, to secure manufacturing. But it was an eight-day impact where we weren't able to ship or manufacture.”
“Second quarter represented a solid quarter for Boston Scientific while we continue to navigate a dynamic environment. Total company organic sales grew 7% versus our guide of 5 to 7, driven by our interventional cardiology, endoscopy, and neuromodulation business.”
“As you said, we're very proud of the company. What we've built over the years, the markets that we're competing in, we think we still compete in markets that grow at least 8%, as we said, our investor last year.”
“In 2025, we achieved over $20 billion in sales and for the second year in a row, delivered mid-teens growth, surpassing our financial goals that we set at the beginning of the This outstanding and highly differentiated performance was fueled by innovation and execution across our business units in the winning spirit…”
“We're pleased with another quarter of excellent results, with momentum continuing fueled by new product innovation, clinical evidence, and our talented teams across the globe.”
Medical Devices · Healthcare
CEO
